Stem Cell Differentiation via ALK-FGF-ERK Pathway Inhibition

Resolve Bottlenecks,
Find Innovative SolutionsGenerate Solutions

Solution Overview

Problem

The differentiation of human pluripotent stem cells into ectoderm-derived cell types, particularly anterior and posterior neuromesoderm, is slow and inefficient, requiring at least six days, which hinders therapeutic applications and chemical screening.

Innovation Solution

Inhibiting ALK 2/3, FGF, and ERK signaling pathways in combination with modulating WNT signaling to accelerate the differentiation of pluripotent stem cells into anterior ectoderm and posterior neuromesoderm within 24 hours, using inhibitors such as Noggin, Dorsomorphin, SU5402, PD0325901, and activators like CHIR99021.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Loss of time

If conventional differentiation culture conditions are used, then stem cells differentiate into ectoderm germ layer, but the process takes at least 6 days which is slow and inefficient

Engineering Contradiction:

Improvedifferentiation timeVSAvoiddifferentiation efficiency

Core Design Contradiction:

Loss of timeVSProductivity

Solution Approach 1:

The patent applies parameter changes by modifying culture conditions through the addition of specific inhibitors (ALK 2/3 inhibitor, FGF inhibitor, and ERK inhibitor) to accelerate the differentiation process. These chemical parameters transform the differentiation timeline from 6 days to less than 24 hours, directly resolving the time loss and efficiency contradiction.

Inventive Principle:

Principle #35Parameter changes

2Adaptability or versatility

If disparate culture conditions are used for anterior ectoderm and posterior neuromesoderm, then both germ layers can be formed, but the process requires different time frames and is complex

Engineering Contradiction:

Improvegerm layer formation capabilityVSAvoidculture condition complexity

Core Design Contradiction:

Adaptability or versatilityVSDevice complexity

Solution Approach 1:

The patent merges the differentiation of anterior ectoderm and posterior neuromesoderm into a single unified culture condition. By combining ALK 2/3 inhibitor, FGF inhibitor, and ERK inhibitor in one culture medium, the patent simultaneously generates both germ layers from pluripotent stem cells within less than 24 hours, eliminating the need for separate culture conditions and time frames.

Inventive Principle:

Principle #5Merging (Combining)

Data Source

PatentUS20260071177A1Acceleration of stem cell differentiation

Publication Date: 2026.03.12 REGENTS OF THE UNIVERSITY OF MINNESOTA

AI summary

Provide herein are compositions, methods and kits to accelerate pluripotent stem cell differentiation.